Top Markets
Coin of the day
Shanghai Pioneer Holding Ltd Shanghai Pioneer Holding Ltd

Shanghai Pioneer Holding Ltd

1345
Rank in Stocks #15767
China Pioneer Pharma Holdings Limited operates as an investment holding... China Pioneer Pharma Holdings Limited operates as an investment holding company, primarily focusing on the marketing, promotion, and distribution of pharmaceutical goods and medical devices within mainland China. The firm maintains an extensive portfolio of pharmaceutical products addressing diverse therapeutic areas, including ophthalmology, pain management, cardiovascular health, immunology, gynecology, and gastroenterology. Its medical device offerings encompass solutions for ophthalmology, orthopedics, dentistry, and wound care. The company supplies its products to a wide client base, including hospitals, various medical institutions, and pharmacies. Additionally, it engages in the sale of supporting tools, leases related equipment, provides dental apparatus, and distributes imported prescription products under license. Established in 1996, China Pioneer Pharma Holdings Limited is headquartered in Shanghai, PRC, and functions as a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
Share Price
$0.28655476
Last synced: 2026-08-28
Market Cap
$332.11M
Change (1 day)
4.19%
Change (1 year)
11.16%
Country
CN
Trade Shanghai Pioneer Holding Ltd (1345)

Category

Number of shares outstanding for Shanghai Pioneer Holding Ltd (1345)
Number of shares outstanding as of September 2026: 0
According to Shanghai Pioneer Holding Ltd latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of September 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Shanghai Pioneer Holding Ltd (1345) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors